Dietary advanced glycation end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus - Wikidata - wikimedia - TriplyDB

Dietary advanced glycation end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus

Dietary advanced glycation end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus

http://www.wikidata.org/entity/Q42519686

about

Dietary Advanced Glycation End Products and Risk Factors for Chronic Disease: A Systematic Review of Randomised Controlled Trials Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance Dietary advanced glycation end products and their role in health and disease Nutritional psychiatry research: an emerging discipline and its intersection with global urbanization, environmental challenges and the evolutionary mismatch Consumption of diets with low advanced glycation end products improves cardiometabolic parameters: meta-analysis of randomised controlled trials.Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial Diet and Diabetic Kidney Disease: Plant Versus Animal Protein.Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial.Contribution of dietary advanced glycation end products (AGE) to circulating AGE: role of dietary fat Renovascular hypertension leads to DNA damage and apoptosis in bone marrow cells.Effect of advanced glycation end product intake on inflammation and aging: a systematic review.Effect of diet-derived advanced glycation end products on inflammation.Inhibition of tumor suppressor p53 preserves glycation-serum induced pancreatic beta-cell demise.Dietary Advanced Glycation End Products and Cardiometabolic Risk.Recent Science and Clinical Application of Nutrition to Coronary Heart Disease.Effects of ferric citrate supplementation on advanced glycation end products in a rat model of streptozotocin/nicotinamide-induced diabetes.The Role of Advanced Glycation End Products in Diabetic Vascular Complications.Advanced glycation end products and risk of hypertension in Iranian adults: Tehran lipid and glucose study.

P2860

Q26764769-52FE09FB-4406-4C87-91A8-BD654A731CBC Q26800114-4B2ACA83-60D1-4056-94C4-C4542C4E22D5 Q26801247-6D345176-D702-4339-8684-F899991E7C46 Q30838578-1C5684C5-0151-4AEE-86D7-C7777388FC54 Q33720039-4BE08478-8B0D-4F68-85ED-99BAA3E9892E Q33829924-C0422ECF-FE9B-4F52-8AC9-D1F595939EAC Q33889472-E1A23173-C727-4D67-835D-104A04297366 Q33904838-39DACD53-2BC0-4A1B-8745-D550A7924D9E Q36458415-01DCB4ED-19BB-457A-BD5E-68B75382025B Q37052097-F0440156-4C98-4D22-BDA6-E9A21591BE69 Q38250741-9288FE6E-8303-4786-86B1-02389D470963 Q38588208-45E35D96-D41B-4EEB-8A37-EDD7C27BDFC1 Q38736612-00166E31-E11F-496E-BDAD-E71B90E4F3A9 Q39427655-0D33B7F8-B735-4AF1-8ADE-4A0FD8E6C57C Q50126071-3041EAB5-B0AE-4F2E-9F5B-30F60F40A4C4 Q51318083-07956ABA-7534-4F6A-AAAC-29974E6ADD15 Q55416114-ADE63B9C-38E8-4CA4-A52E-63F47D5E408A Q55433171-0896AE60-C8F6-43AA-9115-1611A50B87D7

P2860

Dietary advanced glycation end products restriction diminishes inflammation markers and oxidative stress in patients with type 2 diabetes mellitus

http://www.wikidata.org/entity/Q42519686

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Dietary advanced glycation end ...... with type 2 diabetes mellitus

@en

Dietary advanced glycation end ...... with type 2 diabetes mellitus

@nl

type

label

Dietary advanced glycation end ...... with type 2 diabetes mellitus

@en

Dietary advanced glycation end ...... with type 2 diabetes mellitus

@nl

prefLabel

Dietary advanced glycation end ...... with type 2 diabetes mellitus

@en

Dietary advanced glycation end ...... with type 2 diabetes mellitus

@nl

P1433

Q42519686-F3668CE7-FD9C-4F88-A577-5C70BF92AF67

P1476

Q42519686-49094104-557C-4372-A8E2-79427BE25DD8

P2093

Q42519686-3135F146-AEB8-4EAF-B3BC-56EDD1EA558A

Q42519686-3271EDB0-3CD6-4847-9686-B2E722BEB326

Q42519686-8328CFFD-E2EE-4876-884E-AC449F67F02F

Q42519686-9020F6F5-7150-4AB2-B6B2-FCE1F6214D75

Q42519686-E148F86E-30B9-49B1-86E7-E10CDE46A5BA

P2860

Q42519686-033523AE-B368-4E71-B1A7-74D076CAB5FC

Q42519686-0DEE1754-FE46-4CE1-B913-97C21AD7A190

Q42519686-1169B5EE-803B-4DEA-9C2A-43967780304E

Q42519686-1A031421-1A99-40EE-93F9-11175887F480

Q42519686-1F3AC3E5-0660-447B-954A-A42CAF329FEE

Q42519686-2A0EE205-0CCC-43D5-9459-1AB499617CB1

Q42519686-2F1A9E23-62ED-411C-804F-01853005826E

Q42519686-2F878F4B-F73E-4049-85A3-932099A5542B

Q42519686-3F1E6046-70F8-4B0D-A07A-845C55B72AA1

Q42519686-475CCD3D-4353-48A3-A1C6-D4FD7FB2B1C4

P304

Q42519686-9C6F9707-B581-45B3-8D1F-F74A82AD2016

P31

Q42519686-0A0A282D-BBEC-4876-8AEA-A6561B459194

P356

Q42519686-7C2FCE16-7E35-4B1B-BE57-69ED169773A3

P433

Q42519686-FEB93E14-9C98-4052-B5C7-6F695B04186D

P478

Q42519686-3E153340-E1B4-4D1A-8E88-A900DBF6320B

P577

Q42519686-56D26ADF-7DC5-481E-AA55-3B4B7F9AA64D

P5875

Q42519686-3635121D-96FD-4BDF-882C-12AF1C88A04E

P698

Q42519686-CA0F138D-92F2-4382-A316-482D18593DB6

P921

Q42519686-26B59A6C-D311-4D1A-BFBB-AE366B6F246C

Q42519686-DFEA7780-F144-4D5E-A1F3-6B3C52AC3BA4

P932

Q42519686-B0D10832-AEF0-4C21-AC61-46D9A3BF00D9

P356

P1433

Journal of Clinical Biochemistry and Nutrition

P1476

Dietary advanced glycation end ...... with type 2 diabetes mellitus

@en

P2093

Claudia Luévano-Contreras

http://www.w3.org/2001/XMLSchema#string

Juan M Malacara

http://www.w3.org/2001/XMLSchema#string

Katarzyna Wrobel

http://www.w3.org/2001/XMLSchema#string

Kazimierz Wrobel

http://www.w3.org/2001/XMLSchema#string

Ma Eugenia Garay-Sevilla

http://www.w3.org/2001/XMLSchema#string

P2860

Advanced glycation end products in foods and a practical guide to their reduction in the diet

Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging

Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus.

Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy

Advanced glycoxidation end products in commonly consumed foods.

Restriction of advanced glycation end products improves insulin resistance in human type 2 diabetes: potential role of AGER1 and SIRT1

Maillard reaction products in tissue proteins: new products and new perspectives.

Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction.

Protein-bound advanced glycation endproducts (AGEs) as bioactive amino acid derivatives in foods.

Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects.

P304

22-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3164/JCBN.12-40

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235364046

http://www.w3.org/2001/XMLSchema#string

P698

23341693

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3541414

http://www.w3.org/2001/XMLSchema#string